Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Change in Acquisitions & Divestments (2022 - 2025)

Stoke Therapeutics has reported Change in Acquisitions & Divestments over the past 4 years, most recently at $37.4 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 24.66% year-over-year to $37.4 million; the TTM value through Dec 2025 reached $136.6 million, up 127.63%, while the annual FY2025 figure was $136.6 million, 127.63% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $37.4 million at Stoke Therapeutics, up from $33.2 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $79.0 million in Q3 2022 and troughed at $9.0 million in Q1 2022.
  • A 4-year average of $30.9 million and a median of $30.0 million in 2024 define the central range for Change in Acquisitions & Divestments.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 491.67% in 2023 and later tumbled 81.22% in 2024.
  • Year by year, Change in Acquisitions & Divestments stood at $18.0 million in 2022, then fell by 16.8% to $15.0 million in 2023, then surged by 100.0% to $30.0 million in 2024, then rose by 24.66% to $37.4 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for STOK at $37.4 million in Q4 2025, $33.2 million in Q3 2025, and $33.2 million in Q2 2025.